BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 30076175)

  • 1. AML suppresses hematopoiesis by releasing exosomes that contain microRNAs targeting c-MYB.
    Hornick NI; Doron B; Abdelhamed S; Huan J; Harrington CA; Shen R; Cambronne XA; Chakkaramakkil Verghese S; Kurre P
    Sci Signal; 2016 Sep; 9(444):ra88. PubMed ID: 27601730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving the solubility and antileukemia activity of Wnt/β-catenin signaling inhibitors by disrupting molecular planarity.
    Ai Y; Sakamuru S; Imler G; Xia M; Xue F
    Bioorg Med Chem; 2022 Sep; 69():116890. PubMed ID: 35777269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological targeting of β-catenin in normal karyotype acute myeloid leukemia blasts.
    Griffiths EA; Golding MC; Srivastava P; Povinelli BJ; James SR; Ford LA; Wetzler M; Wang ES; Nemeth MJ
    Haematologica; 2015 Feb; 100(2):e49-52. PubMed ID: 25381132
    [No Abstract]   [Full Text] [Related]  

  • 4. MYB insufficiency disrupts proteostasis in hematopoietic stem cells, leading to age-related neoplasia.
    Clarke ML; Lemma RB; Walton DS; Volpe G; Noyvert B; Gabrielsen OS; Frampton J
    Blood; 2023 Apr; 141(15):1858-1870. PubMed ID: 36603185
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Almeida A; T'Sas S; Pagliaro L; Fijalkowski I; Sleeckx W; Van Steenberge H; Zamponi R; Lintermans B; Van Loocke W; Palhais B; Reekmans A; Bardelli V; Demoen L; Reunes L; Deforce D; Van Nieuwerburgh F; Kentsis A; Ntziachristos P; Van Roy N; De Moerloose B; Mecucci C; La Starza R; Roti G; Goossens S; Van Vlierberghe P; Pieters T
    Hemasphere; 2024 Mar; 8(3):e51. PubMed ID: 38463444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. hnRNPA0 promotes MYB expression by interacting with enhancer lncRNA MY34UE-AS in human leukemia cells.
    Liu C; Wang Y; Shi M; Tao X; Man D; Zhang J; Han B
    Biochem Biophys Res Commun; 2024 Jun; 724():150221. PubMed ID: 38865811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Exosomes from Septic Mice Activate NF-κB/MIR17HG Pathway in Macrophages.
    Wu SC; Rau CS; Wu YC; Wu CJ; Tsai CW; Huang LH; Lin CW; Lu TH; Yang MY; Hsieh CH
    Biomedicines; 2024 Feb; 12(3):. PubMed ID: 38540147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A diagnostic circulating miRNA signature as orchestrator of cell invasion via TKS4/TKS5/EFHD2 modulation in human gliomas.
    Díaz Méndez AB; Sacconi A; Tremante E; Lulli V; Caprara V; Rosanò L; Goeman F; Carosi M; Di Giuliani M; Vari G; Silvani A; Pollo B; Garufi C; Ramponi S; Simonetti G; Ciusani E; Mandoj C; Scalera S; Villani V; Po A; Ferretti E; Regazzo G; Rizzo MG
    J Exp Clin Cancer Res; 2023 Mar; 42(1):66. PubMed ID: 36932446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intricate crosstalk between MYB and noncoding RNAs in cancer.
    Hu D; Shao W; Liu L; Wang Y; Yuan S; Liu Z; Liu J; Zhang J
    Cancer Cell Int; 2021 Dec; 21(1):653. PubMed ID: 34876130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-125a-3p and MiR-320b Differentially Expressed in Patients with Chronic Myeloid Leukemia Treated with Allogeneic Hematopoietic Stem Cell Transplantation and Imatinib Mesylate.
    Martins JRB; Moraes LN; Cury SS; Capannacci J; Carvalho RF; Nogueira CR; Hokama NK; Hokama POM
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of MYB by distal enhancer elements in human myeloid leukemia.
    Li M; Jiang P; Cheng K; Zhang Z; Lan S; Li X; Zhao L; Wang Y; Wang X; Chen J; Ji T; Han B; Zhang J
    Cell Death Dis; 2021 Feb; 12(2):223. PubMed ID: 33637692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The transcription factor TAL1 and miR-17-92 create a regulatory loop in hematopoiesis.
    Meyer A; Herkt S; Kunze-Schumacher H; Kohrs N; Ringleb J; Schneider L; Kuvardina ON; Oellerich T; Häupl B; Krueger A; Seifried E; Bonig H; Lausen J
    Sci Rep; 2020 Dec; 10(1):21438. PubMed ID: 33293632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of microRNA Expression Profile in Chronic Myeloid Leukemia Patients Newly Diagnosed and Treated by Allogeneic Hematopoietic Stem Cell Transplantation.
    Martins JRB; de Moraes LN; Cury SS; Dadalto J; Capannacci J; Carvalho RF; Nogueira CR; Hokama NK; Hokama POM
    Front Oncol; 2020; 10():1544. PubMed ID: 33014798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-17-92 enriched exosomes derived from multipotent mesenchymal stromal cells enhance axon-myelin remodeling and motor electrophysiological recovery after stroke.
    Xin H; Liu Z; Buller B; Li Y; Golembieski W; Gan X; Wang F; Lu M; Ali MM; Zhang ZG; Chopp M
    J Cereb Blood Flow Metab; 2021 May; 41(5):1131-1144. PubMed ID: 32811262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflexibility of the plasma miRNA response following a high-carbohydrate meal in overweight insulin-resistant women.
    Ramzan F; D'Souza RF; Durainayagam BR; Milan AM; Roy NC; Kruger MC; Henry CJ; Mitchell CJ; Cameron-Smith D
    Genes Nutr; 2020; 15():2. PubMed ID: 32042348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Wnt/β-Catenin/LEF1 Pathway Promotes Cell Proliferation at Least in Part Through Direct Upregulation of miR-17-92 Cluster.
    Mu F; Huang J; Xing T; Jing Y; Cui T; Guo Y; Yan X; Li H; Wang N
    Front Genet; 2019; 10():525. PubMed ID: 31191623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional activation of the miR-17-92 cluster is involved in the growth-promoting effects of MYB in human Ph-positive leukemia cells.
    Spagnuolo M; Regazzo G; De Dominici M; Sacconi A; Pelosi A; Korita E; Marchesi F; Pisani F; Magenta A; Lulli V; Cordone I; Mengarelli A; Strano S; Blandino G; Rizzo MG; Calabretta B
    Haematologica; 2019 Jan; 104(1):82-92. PubMed ID: 30076175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of EVI1 transcription by the LEF1/β-catenin complex with p53-alteration in myeloid blast crisis of chronic myeloid leukemia.
    Manachai N; Saito Y; Nakahata S; Bahirvani AG; Osato M; Morishita K
    Biochem Biophys Res Commun; 2017 Jan; 482(4):994-1000. PubMed ID: 27908728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-96 acts as a tumor suppressor via targeting the BCR-ABL1 oncogene in chronic myeloid leukemia blastic transformation.
    Huang T; Fu Y; Wang S; Xu M; Yin X; Zhou M; Wang X; Chen C
    Biomed Pharmacother; 2019 Nov; 119():109413. PubMed ID: 31518872
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.